- Correction
- Open access
- Published:
Correction: Meeting abstracts from the 11th edition of the European conference on Rare Diseases & Orphan Products (ECRD) 2022
Orphanet Journal of Rare Diseases volume 18, Article number: 370 (2023)
The Original Article was published on 02 June 2023
Correction: Orphanet Journal of Rare Diseases (2023) 18:118 https://doi.org/10.1186/s13023-023-02707-4
P3
Innovating for people living with a rare disease: Why partnerships are key for the European OMP ecosystem
Christian Jervelund1,*, Julia S. Wahl2, Tuomas Haanperä3, Emil Löfroth4, Nikolaj Siersbæk1, Elisa Pau2, Laura Virtanen1, Toon Digneffe5 and Luana Banu5
1Copenhagen Economics, Copenhagen, Denmark
2Copenhagen Economics, Brussels, Belgium
3Copenhagen Economics, Helsinki, Finland
4Copenhagen Economics, Stockholm, Sweden
5Takeda Pharmaceutical Company, Opfikon, Switzerland
*Corresponding author: cj@copenhageneconomics.com
Orphanet Journal of Rare Diseases 2023: P3
Following publication of the original article [1], we have been notified that Fig. 1 in abstract “Innovating for people living with a rare disease: Why partnerships are key for the European OMP ecosystem” was published incorrectly. Please see below incorrect Fig. 1:
Fig. 1 Effect of an increase in length of ME (left) and partnership solution (right) on the rNPV of a hypothetical ultra-rare OMP [3]. ME = market exclusivity, rNPV = risk-adjusted net present value
Correct Fig. 1 is:
Fig. 1 Effect of an increase in length of ME (left) and partnership solution (right) on the rNPV of a hypothetical ultra-rare OMP [3]. ME = market exclusivity, rNPV = risk-adjusted net present value
The original article was updated.
Reference
Orphanet Journal of Rare Diseases. Meeting abstracts from the 11th edition of the European conference on Rare Diseases & Orphan Products (ECRD) 2022. 2023;18:118. https://doi.org/10.1186/s13023-023-02707-4.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Correction: Meeting abstracts from the 11th edition of the European conference on Rare Diseases & Orphan Products (ECRD) 2022. Orphanet J Rare Dis 18, 370 (2023). https://doi.org/10.1186/s13023-023-02960-7
Published:
DOI: https://doi.org/10.1186/s13023-023-02960-7